$875 Billion Drug Bill Looms

A close-up view of a variety of colorful pills and tablets stacked together

America’s prescription-drug dependence has quietly become a budget-breaker and a safety risk for millions of families—right as overall spending is projected to surge toward $875 billion by 2026.

Story Snapshot

Polling shows daily prescription use jumped from 56% of adults in 2019 to 70% in more recent surveying, signaling a major shift in routine healthcare behavior.
Cost pressures are driving non-adherence: 24% of adults prescribed medication report skipping doses or not taking medicine because of cost in the past year.
Older Americans face heavy “polypharmacy” exposure, with 37% of adults ages 55+ reporting four or more prescriptions each day.
Lower-income households report higher rates of skipped medication, and government-assisted insurance plays a growing role for people on multiple daily prescriptions.

Daily medication use is rising faster than many families’ paychecks

Recent polling data shows a large share of the country now treats prescriptions as a daily necessity, not an occasional tool. One survey found the percentage of adults taking at least one prescription medication daily rose from 56% in 2019 to 70% in later polling. Other national data has long shown high usage among seniors, including reports that 85% of adults 60 and older took at least one prescription drug in a recent month.

For many conservative households already weary from years of inflation and runaway costs, that trend matters because it turns pharmacy prices into a kitchen-table issue. The research also indicates the growth is not limited to one demographic slice; it spans age groups and income levels. What remains unclear from the available data is how much of the increase reflects shifting medical needs versus prescribing habits that expanded during and after the pandemic era.

Cost-driven non-adherence is a warning sign, not a “personal choice” problem

The most concrete red flag in the research is what Americans do when prices climb: they ration care. Polling cited in the research indicates nearly one-quarter of adults prescribed medication—24%—skipped taking medication in the past year because of cost. Among adults earning under $35,000, the share reporting skipped medication rose to 31%, compared with 21% in the $75,000–$125,000 bracket.

Those figures point to a structural affordability problem with real health consequences, especially for chronic conditions where missed doses can lead to costly complications. The research also notes that groups including younger adults, Hispanic adults, people taking four or more medications, and households under $40,000 report high levels of prescription avoidance behaviors—such as not filling prescriptions, substituting over-the-counter products, or skipping doses. The sources do not quantify resulting hospitalizations, but they flag downstream burdens on the healthcare system.

Polypharmacy is becoming normal—even as long-term risks remain unsettled

The research describes a major change in American medicine: patients taking prescriptions are now about as likely to be taking five or more drugs at the same time as they are to be taking only one. That kind of polypharmacy can be clinically necessary, but it also raises the risk of drug interactions and adverse events—especially when prescriptions accumulate over decades. Researchers emphasize that long-term outcomes are still being studied.

Age patterns in the data help explain why families feel this trend so sharply. The research highlights that 37% of adults ages 55 and older report taking four or more prescriptions daily. That degree of daily reliance can make seniors and their caregivers highly vulnerable to price hikes, formulary changes, or shortages. From a limited-government perspective, it also intensifies the policy stakes because medication purchasing and insurance decisions increasingly influence household autonomy and financial stability.

Lifetime reliance is becoming the expectation, especially for women

A striking set of findings reframes the issue beyond year-to-year costs: Americans are spending enormous portions of their lives on prescription drugs. The research reports that women born in 2019 can expect to spend 60% of their lives taking prescription medications, compared with 48% for men. Experts cited in the research stress they are not labeling medication use as inherently “good” or “bad,” but they raise concern about how much is too much.

The same research attributes much of the gender gap not simply to contraception, but to higher use of psychotherapeutic drugs and painkillers among women—categories that carry their own dependency and side-effect debates. The sources don’t provide a full breakdown of what’s driving prescribing choices in each case, which limits conclusions about causality. Still, the lifetime perspective underscores a hard reality: America’s health system increasingly manages normal life through long-term pharmaceuticals.

Spending projections and reliance on government assistance raise policy pressure

The money involved is massive. The research cites prescription drug expenditures of $335 billion in 2018 and projects spending could reach $875 billion by 2026—about 15.4% of national health expenditures. It also notes out-of-pocket spending represents 14% of drug spending, which translates abstract national totals into direct household exposure. For taxpayers, those figures matter because public programs inevitably feel the strain when private budgets break.

Government-assisted insurance is already a bigger part of the picture for people on multiple medications. The research reports that 31% of Americans taking three or more daily prescriptions rely on government-assisted insurance, up three points from 2019. That combination—rising utilization, rising prices, and rising reliance on public support—creates pressure for reforms that improve affordability without sliding into heavy-handed controls that limit choice, restrict access, or centralize decision-making away from patients and doctors.